This functional cooperation suggests paracrine interactions between SRC and VEGF-C signaling in the tumor microenvironment, since therapeutic inhibition of SRC suppresses VEGF-C expression in pancreatic cancer cells, and impairs the proliferation and sprouting of lymphatic endothelial cells [170]. Here, VEGFC is linked to neoplasm.